Pleomorphic adenoma (benign mixed tumor) is the most common epithelial neoplasm of the lacrimal gland, accounting for approximately 50% of all lacrimal gland masses. Histologically, it contains both epithelial and mesenchymal (myxoid, chondroid, myoepithelial) components, hence the designation 'mixed tumor.' It typically presents in the 4th-5th decades with a slight male predominance. Clinically, it manifests as slowly progressive, painless proptosis with inferomedial globe displacement. Radiologically, it appears as a well-circumscribed, oval or lobulated mass in the lacrimal fossa; bone remodeling (pressure erosion) is characteristic but bone destruction is absent — this feature is critical for differentiation from adenoid cystic carcinoma. Intact capsule resection via lateral orbitotomy (en bloc excision) is the gold standard treatment; incisional biopsy is strictly contraindicated because disruption of capsule integrity leads to tumor seeding and dramatically increased recurrence risk. The risk of malignant transformation (carcinoma ex-pleomorphic adenoma) can reach 10-20% in cases with prolonged follow-up without treatment; therefore, early diagnosis and complete surgical excision are the most important prognostic factors.
Age Range
20-60
Peak Age
40
Gender
Equal
Prevalence
Uncommon
Pleomorphic adenoma originates from the intercalated duct cells and myoepithelial cells of the lacrimal gland; this dual cell origin explains why the tumor exhibits both epithelial (glandular/ductal) and mesenchymal (myxoid, chondroid, fibrous) differentiation. Due to its slow growth, the tumor causes pressure erosion (remodeling) rather than aggressive destruction of surrounding bone — this manifests radiologically as expansion of the lacrimal fossa with sclerotic margins, representing the fundamental distinguishing point from the permeative bone destruction seen in malignant tumors. As the imaging correlate of histological heterogeneity, heterogeneous signal on T2-weighted MRI sequences is observed: myxoid/chondroid areas produce high T2 signal while cellular epithelial and fibrous areas produce low signal. The capsule is generally preserved but may have focal areas of thinning; these pseudopods are the source of recurrence and explain why maintaining capsule integrity during surgery is critically important. In the setting of prolonged untreated disease, accumulation of recurrent genetic instability and particularly PLAG1 and HMGA2 gene rearrangements can lead to malignant transformation (carcinoma ex-pleomorphic adenoma).
The presence of a well-circumscribed mass in the lacrimal fossa with bone remodeling (fossa expansion with pressure erosion and sclerotic margin) and absence of bone destruction is the most distinguishing radiological feature of pleomorphic adenoma. This finding reflects the pressure effect of a slowly growing benign tumor on bone and is the key point for differentiation from malignant lacrimal gland tumors (particularly adenoid cystic carcinoma) that show aggressive bone destruction. Thin-section CT (≤1 mm) with bone window algorithm reconstruction is mandatory for bone remodeling assessment.
A well-circumscribed, oval or lobulated, isodense or slightly hyperdense mass is seen in the lacrimal fossa. Bone remodeling (pressure-related fossa expansion with thin sclerotic bony margin) is characteristic; bone destruction is absent. The mass is typically 2-4 cm in diameter, causing smooth expansion of the lacrimal fossa. Internal calcification is uncommon but may be seen in long-standing lesions, reflecting chondroid differentiation. Preservation of orbital fat planes is an important finding favoring benignity.
Report Sentence
A well-circumscribed, oval mass measuring approximately ___ x ___ mm is identified in the lacrimal fossa with smooth bone remodeling (pressure erosion) but without bone destruction; findings are consistent with pleomorphic adenoma.
On contrast-enhanced CT, the mass demonstrates heterogeneous enhancement. Prominent enhancement is seen in solid epithelial components while myxoid and cystic degeneration areas show no enhancement. The enhancement pattern reflects the tumor's internal architecture: cellular areas are densely vascularized showing prominent enhancement while avascular myxoid stroma remains unenhanced. A thin, smoothly enhancing capsule may be visualized around the mass. Signs of invasion into surrounding tissues (fat plane obliteration, extraocular muscle infiltration) are absent.
Report Sentence
On contrast-enhanced series, the mass demonstrates heterogeneous enhancement with prominent enhancement in solid components and no enhancement in myxoid areas; no evidence of invasion into surrounding tissues is identified.
On T1-weighted MRI, an iso- to hypointense, well-defined mass relative to orbital fat is seen in the lacrimal fossa. The mass margins are sharp, and a thin low-signal capsule may be visible between the mass and surrounding orbital fat. Focal T1 hyperintensity may be seen in areas of hemorrhagic degeneration. The mass generally shows homogeneous or mildly heterogeneous signal characteristics. Preservation of orbital fat planes and normal morphology of extraocular muscles are important findings favoring benignity. On fat-suppressed T1, the mass shows intermediate signal intensity and hemorrhagic components become more conspicuous.
Report Sentence
On T1-weighted sequences, an iso- to hypointense well-defined mass relative to orbital fat is identified in the lacrimal fossa with a thin hypointense surrounding capsule.
On T2-weighted MRI, the mass characteristically shows heterogeneous signal — this is the most diagnostic MR feature of pleomorphic adenoma. Myxoid and chondroid components produce high T2 signal (high free water content) while cellular epithelial areas and fibrous stroma show low-to-intermediate signal intensity. This 'mottled' heterogeneous T2 pattern directly reflects the tumor's mixed histological composition. The capsule is seen as a thin low-signal ring on T2. Areas of cystic degeneration produce markedly high T2 signal. If there is compression against the globe, globe shape distortion may be seen but this represents mechanical compression effect rather than invasion.
Report Sentence
On T2-weighted sequences, the mass demonstrates heterogeneous signal characteristics with a mixture of high-signal myxoid/chondroid areas and low-signal cellular/fibrous areas; this pattern is consistent with pleomorphic adenoma.
On diffusion-weighted imaging (DWI), pleomorphic adenoma shows a variable diffusion pattern. Mild diffusion restriction may be seen in cellular epithelial components, but marked restriction (very low ADC values) is generally absent — this feature helps in differentiation from highly cellular malignant tumors. ADC values are typically in the range of 1.0-1.8 × 10⁻³ mm²/s. Myxoid and cystic components show free diffusion (high ADC). The heterogeneous ADC map reflects the tumor's mixed composition. In cases developing malignant transformation, newly appearing marked diffusion restriction (ADC <0.8 × 10⁻³ mm²/s) should be an alerting finding.
Report Sentence
On diffusion-weighted imaging, the mass shows variable diffusion pattern without marked diffusion restriction (ADC: ___ × 10⁻³ mm²/s); no findings suggesting malignancy are identified.
On contrast-enhanced MRI (post-gadolinium fat-suppressed T1), the mass shows heterogeneous enhancement. Prominent and early enhancement is seen in solid epithelial components while myxoid and cystic areas remain unenhanced or show late and minimal enhancement. The capsule is seen as a thin, smooth, continuously enhancing ring — assessment of capsule integrity is critically important for preoperative planning. On dynamic contrast-enhanced MRI, solid components show rapid early enhancement and plateau or slow washout (Type I or Type II kinetic curve). No enhancing extension into surrounding tissues (extraocular muscles, periorbita, intracranial structures) is identified.
Report Sentence
On contrast-enhanced fat-suppressed T1-weighted sequences, the mass demonstrates heterogeneous enhancement with an intact, thin, smoothly enhancing surrounding capsule; no evidence of invasion into surrounding tissues is identified.
On B-mode ultrasonography, a well-defined, oval or lobulated, heterogeneously echogenic mass is identified in the lacrimal fossa region. The mass generally shows hypoechoic or mixed echogenicity relative to surrounding orbital fat. A thin hyperechoic capsule may be visible. Internal cystic or myxoid areas are seen as anechoic or hypoechoic foci. Posterior acoustic enhancement may be seen in the presence of cystic/myxoid components. Compression and deformation against the globe can be assessed. Calcified areas appear as strongly shadowing hyperechoic foci. The interface between the lesion, globe, and bony wall should be carefully evaluated.
Report Sentence
On ultrasonography, a well-defined, heterogeneously echogenic mass measuring approximately ___ x ___ mm is identified in the lacrimal fossa region with a thin hyperechoic capsule.
On color Doppler ultrasonography, pleomorphic adenoma generally shows minimal to moderate internal vascularity. Vascular signals are predominantly seen in solid components while myxoid and cystic areas show no vascularity. Regularly distributed, low-to-moderate velocity arterial signals are predominant. Irregular, chaotic vascular pattern (malignancy sign) is absent. On spectral Doppler, low-to-moderate resistive index (RI: 0.5-0.7) is observed — high RI (>0.8) should be alerting for malignancy. Peripheral capsular vascularity may be seen. Overall vascularity degree is proportional to tumor size.
Report Sentence
On color Doppler examination, minimal to moderate internal vascularity localized to solid components is observed without irregular or chaotic vascular pattern.
Criteria
Myxoid and chondroid stroma predominant (>50%), cellular epithelial component minor
Distinct Features
Dominant T2 hyperintense areas on MRI, more homogeneous high T2 signal; hypodense appearance on CT; enhancement minimal to moderate and more homogeneous; this subtype is the most common form and demonstrates the most typical radiological presentation
Criteria
Cellular epithelial component predominant (>50%), myxoid stroma minor
Distinct Features
Lower and more heterogeneous T2 signal on MRI; isodense or slightly hyperdense on CT; enhancement more prominent and heterogeneous; mild diffusion restriction may be seen on DWI; may be confused with malignancy due to cellular predominance but margins remain smooth and capsule intact; risk of malignant transformation is higher in this subtype
Criteria
Prominent cystic degeneration areas present (usually in large, long-standing tumors)
Distinct Features
Prominent T2 hyperintense cystic cavities on MRI (fluid-fluid levels may be present); peripheral enhancement and internal non-enhancing areas on contrast series; anechoic cystic component and posterior acoustic enhancement on US; may reach large sizes (>4 cm); solid-cystic mixed pattern may be confused with dermoid cyst or mucocele
Criteria
Development of carcinomatous transformation in the setting of existing or previously known pleomorphic adenoma; usually in long-standing untreated cases or recurrence after incomplete resection
Distinct Features
Rapid growth and irregularity of margins of previously well-circumscribed mass; capsule destruction and invasion into surrounding tissues; bone destruction instead of remodeling; newly appearing marked diffusion restriction (ADC <0.8 × 10⁻³ mm²/s); periorbital fat plane obliteration; development of pain; perineural spread findings may be present; 'tumor-within-tumor' pattern may be seen in existing lesion
Distinguishing Feature
Adenoid cystic carcinoma shows bone destruction (not remodeling), irregular margins, clinically painful proptosis predominates (<1 year rapid course), perineural spread may be seen; pleomorphic adenoma shows bone remodeling (sclerotic margin), smooth margins, and painless slow growth
Distinguishing Feature
Orbital lymphoma typically shows diffuse orbital infiltration not limited to the lacrimal gland, homogeneous iso-to-hypointense T2 signal (unlike heterogeneous T2 of pleomorphic adenoma), marked diffusion restriction (low ADC), homogeneous enhancement, and bone remodeling is usually absent; bilateral involvement is a strong clue favoring lymphoma
Distinguishing Feature
Idiopathic orbital inflammation (pseudotumor) in dacryoadenitis form can involve the lacrimal gland but generally shows bilateral involvement, diffuse inflammatory changes extending to surrounding tissues (extraocular muscles, orbital fat), diffuse enhancement, and low T2 signal; clinically distinguished by acute onset, pain, and steroid response; bone remodeling is absent
Distinguishing Feature
IgG4-related disease tends to involve lacrimal glands bilaterally and symmetrically; shows homogeneous low-to-intermediate T2 signal, homogeneous enhancement, and diffusion restriction; lacrimal fossa bone remodeling is rare; elevated serum IgG4 and bilateral involvement are distinguishing; histologically storiform fibrosis and obliterative phlebitis are characteristic
Distinguishing Feature
Dermoid cyst typically located at frontozygomatic suture region (more anterior than lacrimal fossa), shows fat density with negative HU values, does not enhance, may contain calcification or fat-fluid levels; presents in childhood; pleomorphic adenoma is seen in posterior lacrimal fossa, solid density, and in middle age
Urgency
routineManagement
surgicalBiopsy
Not NeededFollow-up
Annual imaging if observation chosen; post-surgical follow-up MRI at 6 months then annually for 5 years to monitor for recurrence or malignant transformationPleomorphic adenoma is a benign tumor, but treatment planning is critically important due to the high recurrence rate after incomplete resection (30-50%) and the risk of malignant transformation in long-standing untreated cases (10-20%). The gold standard treatment is en bloc capsular resection via lateral orbitotomy — capsule integrity must be preserved and intraoperative tumor spillage must be prevented. Incisional biopsy is strictly contraindicated because capsule violation leads to tumor seeding and very high recurrence rates. Preoperative MRI is mandatory for assessment of tumor size, capsule integrity, and relationship to surrounding structures. In postoperative follow-up, annual MRI is recommended to monitor for recurrence and malignant transformation. Advanced age, long disease duration, and prior incomplete resection are risk factors for malignant transformation.
Total excision (en-bloc resection) preserving capsule integrity is required. Incomplete excision increases >30% recurrence and malignant transformation risk. Incisional biopsy is contraindicated.